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The transcription factor p63 is critically important for
skin development and maintenance. Processes that
require p63 include epidermal lineage commitment,
epidermal differentiation, cell adhesion, and base-
ment membrane formation. Not surprisingly, altera-
tions in the p63 pathway underlie a subset of
ectodermal dysplasias, developmental syndromes in
which the skin and skin appendages do not develop
normally. This review summarizes the current under-
standing of the role of p63 in normal development
and ectodermal dysplasias.
Journal of Investigative Dermatology (2010) 130, 2352–2358;
doi:10.1038/jid.2010.119; published online 6 May 2010
INTRODUCTION
The epidermis, the outermost component of the skin,
functions as the primary barrier between the organism and
the environment. It protects the organism from microbial,
physical, and chemical assaults, as well as from excessive
water loss. The barrier function of the epidermis is established
during embryogenesis and is maintained postnatally by stem
cells, which are located in the basal layer of the interfollicular
epidermis (Fuchs, 2009). When interfollicular stem cells
divide, they give rise to daughter cells, termed transit
amplifying (TA) cells. After a few rounds of cell division,
TA cells permanently withdraw from the cell cycle, and move
suprabasally to initiate terminal differentiation (Koster and
Roop, 2007). This initial stage of terminal differentiation
results in the formation of the spinous layer, the first
suprabasal cell layer of the epidermis. Spinous keratinocytes
subsequently differentiate into granular keratinocytes. Gran-
ular keratinocytes ultimately die when they form the stratum
corneum, the outermost dead layer of the epidermis. The
cells of the stratum corneum, termed corneocytes, replace
their plasma membrane with a shell of cross-linked proteins.
Together with extracellular lipids, these cross-linked proteins
form the cornified cell envelope, which is the most important
component of the epidermal water barrier (Rice and Green,
1977; Steven and Steinert, 1994). As described in more detail
below, the transcription factor p63 is required for key events
in epidermal development and differentiation, including
epidermal lineage commitment, keratinocyte adhesion,
basement membrane formation, epidermal differentiation,
and barrier formation. Thus, it comes as no surprise that
alterations in the p63 pathway lead to developmental
disorders in which these processes are affected.
P63 IN DEVELOPMENTAL DISORDERS
Developmental disorders caused by alterations in the p63
pathway
As predicted from its critical function in the epidermis,
abnormalities in the p63 pathway have been linked to
several developmental disorders (Figure 1). First, p63 is
mutated in several ectodermal dysplasias, a large group of
developmental disorders in which ectodermal derivatives,
such as the epidermis and its appendages, fail to develop
normally (Rinne et al., 2007). Mutations in p63 were found to
underlie several of these ectodermal dysplasias, including
ectrodactyly, ectodermal dysplasia, and cleft lip (EEC)
(Celli et al., 1999) and ankyloblepharon ectodermal dysplasia
and clefting (AEC or Hay–Wells syndrome) (McGrath et al.,
2001). Interestingly, even though both of these disorders are
caused by mutations in p63, the patients have distinct
abnormalities. For example, severe skin erosions are common
in AEC patients, whereas they are rare in EEC patients
(Brunner et al., 2002; Julapalli et al., 2009). Conversely,
limb abnormalities in EEC patients are generally severe,
whereas they are relatively mild in AEC patients (Brunner
et al., 2002; Bree, 2009; Sutton et al., 2009). These
differences in phenotypic outcome are a reflection of the
type of mutations found in EEC and AEC patients.
Specifically, mutations in different functional domains of
the p63 protein lead to different cellular defects, and thus to
different diseases. In order to understand the etiology of
these different but related diseases, we need to understand
the functions of the different p63 proteins and protein
domains.
By encoding two different N-termini (TA and DN) and
multiple C-termini (a, b, g, d, and e), the p63 gene generates
multiple protein isoforms (Yang et al., 1998; Mangiulli et al.,
2009). All p63 isoforms contain identical DNA binding and
oligomerization domains. Whereas mutations in the DN
N-terminus or the a C-terminus cause AEC, mutations in the
DNA binding domain cause EEC (Figure 2) (Celli et al., 1999;
McGrath et al., 2001; Rinne et al., 2008). Nevertheless, the
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precise molecular pathway alterations that are triggered by
these mutations are not yet understood.
Another developmental disorder caused by p63 mutations
is split hand/foot malformation (SHFM) (Ianakiev et al., 2000).
SHFM is a non-syndromic developmental disorder in which
patients have severe limb abnormalities (ectrodactyly and
syndactyly) but no other developmental defects (Duijf et al.,
2003). Five independent chromosomal loci have been
associated with SHFM (SHFM1–SHFM5). p63 was mapped
to one of these loci, SHFM4, and mutations in p63 were
found to underlie SHFM associated with this locus (Figures 1
and 2). Even though causative mutations have not been
identified in the remaining four loci, candidate genes for
SHFM have been mapped to these loci. For example, the
SHFM1 locus harbors the DLX5 and DLX6 genes (Scherer
et al., 1994). Interestingly, the limb phenotype of mice that
lack both Dlx5 and Dlx6 phenocopies that of SHFM patients
(Merlo et al., 2002; Robledo et al., 2002). Further, p63
directly induces Dlx5 and Dlx6 expression, suggesting that
SHFM1 and SHFM4 are caused by alterations in the same
genetic pathway (Lo Iacono et al., 2008).
In addition to Dlx5 and Dlx6, mutations in other p63
target genes were also found to underlie several develop-
mental disorders. For example, mutations in the p63 target
gene P-cadherin cause ectodermal dysplasia, ectrodactyly,
and macular dystrophy (EEM) and tricho-dento-osseous
(TDO) syndrome (Kjaer et al., 2005; Shimomura et al.,
2008). Limb abnormalities in patients with ectodermal
dysplasia, ectrodactyly, and macular dystrophy show a
remarkable similarity to those in patients with EEC (Figure 1).
Further, ectodermal dysplasia, ectrodactyly, and macular
dystrophy patients and EEC patients have hair abnormalities.
As P-cadherin was previously found to be involved in hair
follicle morphogenesis, these findings suggest that P-cadherin
is an important mediator of p63 function during limb and hair
development (Jamora et al., 2003). Another target gene of
p63 that has been linked to a developmental disorder is Dlx3,
mutations in which cause tricho-dento-osseous syndrome
(Price et al., 1998; Radoja et al., 2007). In tricho-dento-
osseous syndrome, the mutant Dlx3 proteins have a
dominant-negative function toward the wild-type Dlx3
proteins, thus impairing the function of Dlx3 (Duverger
AEC SHFM4 EEC
p63
Dlx3 P-cadherin Dlx5/6
SHFM1EEMTDO
Figure 1. p63 in developmental disorders. Mutations in p63 or p63 target genes cause developmental disorders. Dominant mutations in p63 underlie
ankyloblepharon ectodermal dysplasia and clefting (AEC), ectrodactyly, ectodermal dysplasia, and cleft lip (EEC), and split hand/foot malformation (SHFM)4,
whereas dominant mutations in the p63 target genes P-cadherin, Dlx3, and Dlx5 and Dlx6 underlie ectodermal dysplasia, ectrodactyly, and macular dystrophy
(EEM), tricho-dento-osseous (TDO) syndrome, and SHFM1, respectively. The common features of EEC, EEM, and SHFM include severe limb abnormalities,
including syndactyly and ectrodactyly (right image; image depicts an EEC patient). A characteristic feature of AEC patients is the presence of severe erosions,
often located to the scalp (left image). Other ectodermal dysplasias caused by mutations in p63 include limb-mammary syndrome and acro-dermato-ungual-
lacrimal-tooth syndrome. Images of AEC and EEC patients are provided by the National Foundation for Ectodermal Dysplasias.
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Figure 2. Mutations in different domains of p63 cause different ectodermal dysplasias. The p63 gene is expressed as multiple isoforms. Isoforms depicted here
are the full-length isoform, TAp63a, and the predominantly expressed p63 isoform in late embryonic and postnatal epidermis, DNp63a. Mutations in the
DNA-binding domain, common to all p63 isoforms, can cause ectrodactyly, ectodermal dysplasia, and cleft lip (EEC) or split hand/foot malformation (SHFM)4.
Mutations in the DN N terminus or the SAM domain (only present in the a C terminus) underlie ankyloblepharon, ectodermal dysplasia, and clefting (AEC). For
an overview of p63 mutations found in ectodermal dysplasia patients, refer to Rinne et al. (2007, 2008). oligo, oligomerization domain; SAM, sterile alpha
motif; TAD, transactivation domain.
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et al., 2008). Interestingly, although p63 induces Dlx3
expression in basal keratinocytes, Dlx3 degrades p63
in suprabasal cell layers, suggesting that these proteins
participate in an intricate feedback loop (Di Costanzo
et al., 2009). Taken together, these data indicate that
mutations in p63 itself and in genes transcriptionally
regulated by p63 can lead to developmental disorders with
similar phenotypes.
Function of mutant p63 proteins
All disorders caused by the p63 mutations identified to date
are inherited in an autosomal dominant manner. However, it
remains unclear how the mutant p63 proteins exert their
dominant function. As the loss of one p63 allele does not
cause ectodermal dysplasia in mice or humans, it appears
that haplo-insufficiency is not the underlying disease
mechanism (Mills et al., 1999; Yang et al., 1999; van
Bokhoven et al., 2001). Recent studies have provided some
insight into the differential regulation of target genes by
mutant p63 proteins expressed in patients. For example,
whereas p63 proteins carrying AEC mutations can activate
the Dlx5 and Dlx6 promoters, p63 proteins carrying EEC or
SHFM mutations cannot, potentially providing an explana-
tion for the lack of limb abnormalities in patients with AEC
(Lo Iacono et al., 2008). However, these studies did not
determine whether mutant p63 proteins affect the function of
wild-type p63 proteins when they are co-expressed, as they
are in ectodermal dysplasia patients. Thus, the function of
mutant p63 proteins in the cellular context in which they are
normally expressed is largely unknown. Further, the mole-
cular basis for the differential target gene activation by
different mutant p63 proteins remains unclear. However, it is
likely that differences in DNA binding characteristics con-
tribute to the differential activation of p63 target genes by
different mutant p63 proteins. In fact, even though mutations
in the p63 DNA binding domain occur only in SHFM and
EEC, alterations in DNA binding characteristics are also
predicted for some AEC mutants, because of conformational
changes in the mutant p63 proteins (McGrath et al., 2001).
Another possible explanation for the differences in target
gene activation may be the differential interaction of mutant
p63 proteins with co-factors required for target gene
activation or repression.
Mouse models
To further understand the role of p63 in developmental
disorders, animal models that mimic these disorders are
imperative. A mouse model that mimics the skin fragility
phenotype observed in AEC patients was recently generated
by downregulating DNp63 in the epidermis (Koster et al.,
2007). Both in mice with reduced epidermal DNp63
expression and in AEC patients, skin erosions were char-
acterized by suprabasal epidermal proliferation, delayed
terminal differentiation, and basement membrane abnormal-
ities (Koster et al., 2009). Together, these abnormalities likely
contribute to the skin fragility observed in AEC patients.
Consistent with the finding that the skin fragility of AEC
patients can be mimicked by downregulating DNp63, mutant
DNp63a proteins expressed in AEC patients function as
dominant-negative molecules, thereby preventing the induc-
tion of p63 target genes. Whether the additional develop-
mental defects in AEC patients are also caused by a
dominant-negative role of the mutant p63 proteins, or
whether mutant p63 proteins also possess a gain-of-function
role, remains to be determined. As the skin phenotypes of
mice with reduced DNp63 expression and AEC patients are
indistinguishable, this mouse model will be a valuable tool
for testing therapeutic approaches that are aimed at treating
skin erosions in AEC patients.
P63 IN EPIDERMAL DEVELOPMENT AND MAINTENANCE
The human developmental disorders caused by alterations in
the p63 pathway clearly demonstrate the importance of p63
in skin and appendage development. To dissect the genetic
pathways controlled by p63, in vitro and in vivo models have
been used (see below). These models have elucidated critical
roles for p63 in the various key steps required for epidermal
development and homeostasis (Figure 3).
Establishment of the epidermal fate
p63 was initially identified on the basis of its sequence
homology with the tumor suppressor gene p53 (Yang et al.,
1998). However, unlike p53, p63 is expressed in a tissue-
specific manner and is primarily expressed in stratified
epithelia, such as the epidermis. Further, whereas p53-
deficient mice are born without major abnormalities, ablating
p63 from the germ line of mice led to striking developmental
abnormalities. Mice lacking p63 were born with a shiny
translucent skin and without any appendages, such as teeth,
hair follicles, and mammary glands (Mills et al., 1999; Yang
et al., 1999). The severe skin phenotype observed in p63-
deficient mice was found to be caused by a complete failure
of epidermal commitment, the process in which the surface
Roles of p63:
Barrier formation
Adhesion
Proliferation
Basement membrane
formationStem cell
Transit amplifying cells
Terminal differentiation
Cornified layer
Spinous layer
Basal layer
Basement membrane
Granular layer
Figure 3. Role of p63 in the epidermis. The epidermis is a stratified
epithelium, which consists of several layers of keratinocytes (indicated on the
left). When interfollicular stem cells, which reside in the basal layer, divide,
they give rise to transit amplifying (TA) cells that constitute most of the basal
layer. When TA cells initiate terminal differentiation, they withdraw from the
cell cycle and move suprabasally, forming the spinous layer. Further
differentiation results in the formation of the granular and cornified cell layers.
p63 is involved in the various processes required for epidermal development,
differentiation, and homeostasis (indicated on the right). Genes involved in
these processes are indicated in the text.
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ectoderm adopts an epidermal fate (Koster et al., 2004; De
Rosa et al., 2009). During normal epidermal development,
commitment to the epidermal lineage involves repression of
the non-epidermal keratin pair K8 and K18 as well as
induction of the epidermal keratin pair K5 and K14 (Jackson
et al., 1981; Byrne et al., 1994). Interestingly, p63 is required
both for the suppression of K8 and K18 and for the induction
of K5 and K14. This was initially illustrated by the observation
that K8 and K18 are aberrantly expressed in the surface
epithelium of mice with a germ line deletion of p63, as well
as in reconstructed human epidermis with decreased p63
expression levels (Koster et al., 2004; Truong et al., 2006; De
Rosa et al., 2009). Conversely, ectopic expression of p63 in
cultured cells, single-layered epithelia, or embryonic stem
cells led to the expression of K5 and K14 (Koster et al., 2004;
Aberdam et al., 2008; Medawar et al., 2008; Romano et al.,
2009). In addition to controlling the expression of keratins,
p63 also directly represses two cell cycle inhibitors, Ink4a
and Arf (Su et al., 2009b). This repression is also critical for
epidermal commitment, as shown by the finding that
epidermal lineage commitment, indicated by the induction
of K5 and K14 expression, in p63-deficient mice can be
rescued by simultaneously ablating either Ink4a or Arf (Su
et al., 2009b). However, even though epidermal commitment
is restored in these rescued mice, the epidermis does not
mature normally, as shown by the heterogeneous expression
of differentiation markers and the apparent absence of a
stratum corneum (Su et al., 2009b). Thus, epidermal
differentiation requires the activation of additional genetic
pathways that are not downstream of Ink4a and Arf.
In addition to the failure to develop an epidermis, p63-
deficient mice also fail to develop appendages. As appendage
development requires extensive epithelial–mesenchymal in-
teractions, the defects in appendage development in p63-
deficient mice are likely to be, in part, secondary to the
failure to develop an epidermis. However, p63 also has a
direct role in appendage development by inducing genes that
are required for the development of different appendages,
such as Dlx5, Dlx6, and P-cadherin (Lo Iacono et al., 2008;
Shimomura et al., 2008). This direct role of p63 in appendage
development may provide an explanation for the existence of
ectodermal dysplasias caused by p63 mutations in which
appendages, but not the epidermis, are affected. In this subset
of ectodermal dysplasias, mutant p63 proteins might still be
able to activate p63 target genes required for normal
development of the interfollicular epidermis, but they may
fail to activate genes required for appendage development.
p63 in basal keratinocytes
In addition to its role in epidermal lineage commitment, p63
is also critical for epidermal differentiation and barrier
formation, both during epidermal morphogenesis and post-
natally (Figure 3). Within late embryonic and postnatal
epidermis, the highest levels of p63 expression are observed
in the basal layer, where it is predominantly expressed as the
DNp63a isoform (Yang et al., 1998; Liefer et al., 2000). The
basal layer is generally thought of as a homogeneous
population of cells. However, it is actually composed of
cells that are progressing along the differentiation pathway,
including interfollicular stem cells, young TA cells, and
mature TA cells. Whereas young TA cells are regularly
cycling, mature TA cells have a limited proliferative capacity
and are ready to embark on the terminal differentiation
program (Lehrer et al., 1998). p63 may have very different
functions in the various cell types within the basal layer. In
fact, this would explain the apparent by contradictory results
that have been obtained regarding the role of p63 in
proliferation of basal keratinocytes. For example, p63 was
found to maintain proliferation of basal keratinocytes, in part
by repressing various cell cycle inhibitors, including p21,
14-3-3s, Ink4a, and Arf, as well as by inducing the
expression of genes required for cell cycle progression,
including ADA and FASN (Westfall et al., 2003; D’Erchia
et al., 2006; Sbisa et al., 2006; Truong et al., 2006;
Lefkimmiatis et al., 2009; Su et al., 2009b). In apparent
contrast, downregulating p63 in basal keratinocytes of mouse
epidermis led to increased proliferation, showing that p63 is
also required for cell cycle exit (Koster et al., 2007). This
induction of cell cycle exit is mediated, in part, by the direct
induction of p57Kip2, a cyclin-dependent kinase inhibitor that
is induced when keratinocytes undergo terminal differentia-
tion (Martinez et al., 1999; Beretta et al., 2005). Further, p63
directly represses the expression of genes required for cell
cycle progression, including cyclin B2 and cdc2 (Testoni and
Mantovani, 2006). This apparent controversy is most easily
explained by postulating that p63 maintains proliferation in
early TA cells, whereas it induces cell cycle exit in mature TA
cells. This difference in p63 function may be caused by the
different expression levels and/or interaction with co-factors
that regulate p63 function.
p63 in differentiation
Whereas DNp63a expression is high in basal keratinocytes,
its expression is reduced to approximately 25% in suprabasal
keratinocytes (King et al., 2006). The rapid downregulation of
DNp63a in suprabasal keratinocytes seems to be mediated by
several processes. First, DNp63a transcripts are degraded by
microRNA-203 (Lena et al., 2008; Yi et al., 2008). As
predicted, microRNA-203 is specifically expressed in supra-
basal keratinocytes whereas it is virtually absent in basal
keratinocytes (Sonkoly et al., 2007; Lena et al., 2008; Yi
et al., 2008). Depletion of microRNA-203 was found to result
in suprabasal proliferation of keratinocytes (Yi et al., 2008).
However, whether the increased proliferation was due to the
observed increase in p63 expression or due to ectopic
expression of other microRNA-203 target genes was not
investigated. In addition to DNp63a transcript degradation,
DNp63a protein is also actively degraded in suprabasal
keratinocytes. This is mediated by several processes, includ-
ing the targeting of DNp63a for degradation through the
proteosomal pathways by the E3 ubiquitin ligase Itch and
p14Arf (Rossi et al., 2006; Vivo et al., 2009). Finally, the p63
target gene Dlx3 promotes DNp63a degradation in supraba-
sal keratinocytes (Di Costanzo et al., 2009).
Together, the above-described mechanisms are responsi-
ble for the rapid functional inactivation of p63 in suprabasal
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keratinocytes. However, despite this active degradation of
DNp63a in suprabasal cell layers, the remaining DNp63a
protein is sufficient to control the important aspects of
keratinocyte differentiation. For example, DNp63a directly
induces IkB kinase a, a critical mediator of cell cycle exit
during keratinocyte differentiation (Koster et al., 2007;
Marinari et al., 2008). Further, DNp63a induces expression
of the terminal differentiation marker K1 (Nguyen et al.,
2006; Ogawa et al., 2008). Finally, DNp63a is also important
for the formation of the epidermal barrier by inducing at least
two genes that are required for barrier formation, Claudin 1
and Alox12 (Lopardo et al., 2008; Kim et al., 2009).
Interestingly, despite the ability of DNp63a to induce genes
required for terminal differentiation and barrier formation, it
does not induce these genes in the basal layer. The most
likely explanation for this observation is that co-factors
required for the induction of terminal differentiation genes
are absent in basal keratinocytes.
p63 in cell–cell adhesion
In addition to regulating epidermal development and
differentiation, p63 is also important for cell–cell adhesion
within the epidermis. A general role for p63 in mediating
cell–cell adhesion was identified by downregulating p63 in
cultured mammary cells (Carroll et al., 2006). Downregulat-
ing p63 in this system led to impaired cell adhesion, as well
as to reduced expression of several components of desmo-
somes, the multi-protein complexes that connect keratino-
cytes (Cheng and Koch, 2004; Carroll et al., 2006). In
addition, p63 was found to directly regulate the expression of
the desmosomal component Perp (Ihrie et al., 2005). In the
absence of Perp expression, mice display severe intra-
epidermal blistering, further underscoring the importance of
Perp in cell adhesion. Consistent with these findings, cell
adhesion defects have also been reported in AEC patients, a
subset of whom display aberrant Perp expression (Payne
et al., 2005; Beaudry et al., 2009).
p63 in basement membrane formation and cell-basement
membrane adhesion
In addition to its role in mediating cell–cell adhesion, p63 is
also important for regulating the adhesion of keratinocytes to
the basement membrane. Adhesion of keratinocytes to the
basement membrane is mediated by integrins, a family of
transmembrane receptors for the basement membrane
protein laminin (Larsen et al., 2006). p63 was found to
induce the expression of several of these integrin subunits,
including integrin a3 (Kurata et al., 2004; Carroll et al.,
2006). Further, p63 is also important for the formation of the
basement membrane, as demonstrated by the basement
membrane defects in mice with reduced DNp63 expression
as well as in AEC patients (Koster et al., 2007, 2009). p63
controls basement membrane formation, at least in part, by
directly inducing the expression of the basement membrane
component Fras1 (Koster et al., 2007). Interestingly, in mice
and humans, Fras1 deficiency causes a severe embryonic
blistering phenotype, demonstrating the importance of Fras1
in basement membrane integrity (McGregor et al., 2003;
Vrontou et al., 2003). Further, in prostate, the basement
membrane associated with p63-expressing cells is thicker and
more uniform than the basement membrane associated with
basal cells that do not express p63 (Liu et al., 2009). Together,
these findings suggest a critical role for p63 in forming and
maintaining the basement membrane.
P63 IN STEM CELLS
In addition to TA cells and differentiating keratinocytes, p63
is also expressed in the stem cells of several tissues, including
the skin. However, a role for p63 in these stem cells has
remained contentious. At least three different stem cell
populations exist in the skin: interfollicular stem cells, bulge
stem cells, and skin-derived precursors (SKPs). Of these, the
interfollicular stem cells and the bulge stem cells regenerate
the epidermis and hair follicle, respectively. Although either
of these stem cell types can contribute to the epidermal or
hair follicle lineage in response to injury, they only contribute
to their own lineage under homeostatic conditions (Claudinot
et al., 2005; Ito et al., 2005). A functional role for p63 in
interfollicular and bulge stem cells was first proposed on the
basis of the phenotype of p63-deficient mice. Some
investigators attributed the absence of epidermal morphogen-
esis in these mice to a premature depletion of stem cells
(Yang et al., 1999). Further, colony-forming assays using
keratinocytes with reduced p63 expression levels resulted in
the formation of smaller colonies, which has been interpreted
as evidence for stem cell depletion (Senoo et al., 2007).
However, whether this apparent lack of proliferation affected
stem cells and/or TA cells was not investigated.
Recently, it was shown that TAp63 isoforms are also
expressed in SKPs, dermal precursor cells that reside in the
dermal sheath and dermal papilla (Fernandes et al., 2004; Su
et al., 2009a). Interestingly, using a conditional TAp63
knockout mouse model, it was found that ablation of
TAp63 from both the dermal and epidermal compartments
led to skin blistering and accelerated aging (Su et al., 2009a).
However, ablation of TAp63 specifically in the epidermis did
not recapitulate these phenotypes, suggesting that TAp63
exerts its role in SKPs and not in the epidermis (Su et al.,
2009a). However, as ablation of TAp63 specifically from
SKPs is currently not technically feasible, the ultimate proof
for a role of TAp63 in SKPs has yet to be generated.
SUMMARY
The involvement of abnormalities in the p63 pathway in a
subset of developmental disorders underscores the impor-
tance of p63 in normal skin and appendage development.
Indeed, animal models and cell culture studies have
identified the roles of p63 in various processes, including
epidermal lineage commitment, epidermal differentiation,
cell adhesion, and basement membrane formation. However,
the function of mutant p63 proteins expressed in ectodermal
dysplasia remains poorly understood. Whereas mutant p63
proteins in some ectodermal dysplasias such as AEC cause
skin fragility, mutant p63 proteins expressed in other
ectodermal dysplasias such as EEC cause limb abnormalities.
These differences are likely caused by differential activation
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of p63 target genes by the different mutant p63 proteins. For
example, whereas EEC mutants may be able to normally
activate p63 target genes involved in skin development and
differentiation, they may fail to activate target genes required
for limb development. Further studies into the role of p63 in
skin and appendage development, as well as into the
molecular role of mutant p63 proteins, will be necessary for
a better understanding of the role of p63 in ectodermal
dysplasias and other developmental disorders.
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